Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.2 USD | +0.33% | +1.74% | +42.06% |
31/05 | Piper Sandler Initiates Immunome With Overweight Rating, $27 Price Target | MT |
21/05 | Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IMMUNOME, INC. | Bio Therapeutic Drugs | +0.33% | +1.74% | +42.06% | +205.22% | - | 91Cr |
- Stock Market
- Equities
- IMNM Stock
- Charts Immunome, Inc.
- Relative Strength Chart